RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2

Takenari Yamashita, Chieko Tadami, Yoshinori Nishimoto, Takuto Hideyama, Daisuke Kimura, Takeshi Suzuki, Shin Kwak

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Adenosine deaminase acting on RNA 2 (ADAR2) catalyzes RNA editing at the glutamine/arginine (Q/R) site of GluA2, and an ADAR2 deficiency may play a role in the death of motor neurons in ALS patients. The expression level of ADAR2 mRNA is a determinant of the editing activity at the GluA2 Q/R site in human brain but not in cultured cells. Therefore, we investigated the extent of Q/R site-editing in the GluA2 mRNA and pre-mRNA as well as the ADAR2 mRNA and GluA2 mRNA and pre-mRNA levels in various cultured cell lines. The extent of the GluA2 mRNA editing was 100% except in SH-SY5Y cells, which have a much lower level of ADAR2 than the other cell lines examined. The ADAR2 activity at the GluA2 pre-mRNA Q/R site correlated with the ADAR2 mRNA level relative to the GluA2 pre-mRNA. SH-SY5Y cells expressed higher level of the GluA2 mRNA in the cytoplasm compared with other cell lines. These results suggest that the ADAR2 expression level reflects editing activity at the GluA2 Q/R site and that although the edited GluA2 pre-mRNA is readily spliced, the unedited GluA2 pre-mRNA is also spliced and transported to the cytoplasm when ADAR2 expression is low.

Original languageEnglish
Pages (from-to)42-48
Number of pages7
JournalNeuroscience Research
Volume73
Issue number1
DOIs
Publication statusPublished - 2012 May

Fingerprint

RNA Editing
Adenosine Deaminase
Cultured Cells
RNA Precursors
RNA
Cell Line
Enzymes
Messenger RNA
Cytoplasm
Motor Neurons
Glutamine
Arginine

Keywords

  • Adenosine deaminase acting on RNA type 2 (ADAR2)
  • AMPA receptor
  • Amyotrophic lateral sclerosis (ALS)
  • GluA2
  • RNA editing
  • Splicing

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2. / Yamashita, Takenari; Tadami, Chieko; Nishimoto, Yoshinori; Hideyama, Takuto; Kimura, Daisuke; Suzuki, Takeshi; Kwak, Shin.

In: Neuroscience Research, Vol. 73, No. 1, 05.2012, p. 42-48.

Research output: Contribution to journalArticle

Yamashita, Takenari ; Tadami, Chieko ; Nishimoto, Yoshinori ; Hideyama, Takuto ; Kimura, Daisuke ; Suzuki, Takeshi ; Kwak, Shin. / RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2. In: Neuroscience Research. 2012 ; Vol. 73, No. 1. pp. 42-48.
@article{b813f2c034b74afb81f03a436c955e2e,
title = "RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2",
abstract = "Adenosine deaminase acting on RNA 2 (ADAR2) catalyzes RNA editing at the glutamine/arginine (Q/R) site of GluA2, and an ADAR2 deficiency may play a role in the death of motor neurons in ALS patients. The expression level of ADAR2 mRNA is a determinant of the editing activity at the GluA2 Q/R site in human brain but not in cultured cells. Therefore, we investigated the extent of Q/R site-editing in the GluA2 mRNA and pre-mRNA as well as the ADAR2 mRNA and GluA2 mRNA and pre-mRNA levels in various cultured cell lines. The extent of the GluA2 mRNA editing was 100{\%} except in SH-SY5Y cells, which have a much lower level of ADAR2 than the other cell lines examined. The ADAR2 activity at the GluA2 pre-mRNA Q/R site correlated with the ADAR2 mRNA level relative to the GluA2 pre-mRNA. SH-SY5Y cells expressed higher level of the GluA2 mRNA in the cytoplasm compared with other cell lines. These results suggest that the ADAR2 expression level reflects editing activity at the GluA2 Q/R site and that although the edited GluA2 pre-mRNA is readily spliced, the unedited GluA2 pre-mRNA is also spliced and transported to the cytoplasm when ADAR2 expression is low.",
keywords = "Adenosine deaminase acting on RNA type 2 (ADAR2), AMPA receptor, Amyotrophic lateral sclerosis (ALS), GluA2, RNA editing, Splicing",
author = "Takenari Yamashita and Chieko Tadami and Yoshinori Nishimoto and Takuto Hideyama and Daisuke Kimura and Takeshi Suzuki and Shin Kwak",
year = "2012",
month = "5",
doi = "10.1016/j.neures.2012.02.002",
language = "English",
volume = "73",
pages = "42--48",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2

AU - Yamashita, Takenari

AU - Tadami, Chieko

AU - Nishimoto, Yoshinori

AU - Hideyama, Takuto

AU - Kimura, Daisuke

AU - Suzuki, Takeshi

AU - Kwak, Shin

PY - 2012/5

Y1 - 2012/5

N2 - Adenosine deaminase acting on RNA 2 (ADAR2) catalyzes RNA editing at the glutamine/arginine (Q/R) site of GluA2, and an ADAR2 deficiency may play a role in the death of motor neurons in ALS patients. The expression level of ADAR2 mRNA is a determinant of the editing activity at the GluA2 Q/R site in human brain but not in cultured cells. Therefore, we investigated the extent of Q/R site-editing in the GluA2 mRNA and pre-mRNA as well as the ADAR2 mRNA and GluA2 mRNA and pre-mRNA levels in various cultured cell lines. The extent of the GluA2 mRNA editing was 100% except in SH-SY5Y cells, which have a much lower level of ADAR2 than the other cell lines examined. The ADAR2 activity at the GluA2 pre-mRNA Q/R site correlated with the ADAR2 mRNA level relative to the GluA2 pre-mRNA. SH-SY5Y cells expressed higher level of the GluA2 mRNA in the cytoplasm compared with other cell lines. These results suggest that the ADAR2 expression level reflects editing activity at the GluA2 Q/R site and that although the edited GluA2 pre-mRNA is readily spliced, the unedited GluA2 pre-mRNA is also spliced and transported to the cytoplasm when ADAR2 expression is low.

AB - Adenosine deaminase acting on RNA 2 (ADAR2) catalyzes RNA editing at the glutamine/arginine (Q/R) site of GluA2, and an ADAR2 deficiency may play a role in the death of motor neurons in ALS patients. The expression level of ADAR2 mRNA is a determinant of the editing activity at the GluA2 Q/R site in human brain but not in cultured cells. Therefore, we investigated the extent of Q/R site-editing in the GluA2 mRNA and pre-mRNA as well as the ADAR2 mRNA and GluA2 mRNA and pre-mRNA levels in various cultured cell lines. The extent of the GluA2 mRNA editing was 100% except in SH-SY5Y cells, which have a much lower level of ADAR2 than the other cell lines examined. The ADAR2 activity at the GluA2 pre-mRNA Q/R site correlated with the ADAR2 mRNA level relative to the GluA2 pre-mRNA. SH-SY5Y cells expressed higher level of the GluA2 mRNA in the cytoplasm compared with other cell lines. These results suggest that the ADAR2 expression level reflects editing activity at the GluA2 Q/R site and that although the edited GluA2 pre-mRNA is readily spliced, the unedited GluA2 pre-mRNA is also spliced and transported to the cytoplasm when ADAR2 expression is low.

KW - Adenosine deaminase acting on RNA type 2 (ADAR2)

KW - AMPA receptor

KW - Amyotrophic lateral sclerosis (ALS)

KW - GluA2

KW - RNA editing

KW - Splicing

UR - http://www.scopus.com/inward/record.url?scp=84862777298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862777298&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2012.02.002

DO - 10.1016/j.neures.2012.02.002

M3 - Article

C2 - 22366356

AN - SCOPUS:84862777298

VL - 73

SP - 42

EP - 48

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 1

ER -